title: Chronic immune thrombocytopentic purpura in children: assessment of rituximab treatment.
authors.forename: Tillmann
authors.initials: T
authors.lastname: Taube
authors.forename: Arend
authors.initials: A
authors.lastname: von Stackelberg
authors.forename: Ursula
authors.initials: U
authors.lastname: Schulte-Overberg
authors.forename: Günter
authors.initials: G
authors.lastname: Henze
authors.forename: Hansjörg
authors.initials: H
authors.lastname: Schmid
authors.forename: Harald
authors.initials: H
authors.lastname: Reinhard
mesh_terms: D000367:Age Factors; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D002648:Child; D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy*; D012074:Remission Induction; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab